Loading…

Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (From the Fushimi AF Registry)

Abstract Creatinine clearance (CrCl) has been widely used to adjust the dosage of non-vitamin K antagonist oral anticoagulants in atrial fibrillation (AF) patients and exclude contraindicated patients. However, there are few available real-world data on the relationship between CrCl and adverse clin...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2017-04, Vol.119 (8), p.1229-1237
Main Authors: Abe, Mitsuru, MD, PhD, Ogawa, Hisashi, MD, Ishii, Mitsuru, MD, Masunaga, Nobutoyo, MD, Esato, Masahiro, MD, PhD, Chun, Yeong-Hwa, MD, PhD, Tsuji, Hikari, MD, PhD, Wada, Hiromichi, MD, PhD, Hasegawa, Koji, MD, PhD, Lip, Gregory Y.H., MD, Akao, Masaharu, MD, PhD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Creatinine clearance (CrCl) has been widely used to adjust the dosage of non-vitamin K antagonist oral anticoagulants in atrial fibrillation (AF) patients and exclude contraindicated patients. However, there are few available real-world data on the relationship between CrCl and adverse clinical outcomes in AF patients. Therefore, we evaluated the clinical characteristics and adverse events in Japanese AF patients stratified by CrCl. We categorized patients in the Fushimi AF Registry, a large prospective community-based Japanese cohort of AF patients, into three groups as follows: (i) CrCl
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2017.01.005